V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003466 | 210009444 | 1.64 | 77.5 | Adjuvant (A) | 2019-11-10 | 2020-01-14 | EC | N | N | TRIAL UNSPECIFIED | 100042368 |
| 210003476 | 210009446 | 1.57 | 70.35 | null | 2020-02-05 | 2020-02-05 | Capecitabine | null | null | CAPECITABINE | 100010778 |
| 210003521 | 210009447 | 1.71 | 62.1 | null | null | 2018-10-20 | PERTUZUMAB + TRASTUZUMAB | N | null | PERTUZUMAB + TRASTUZUMAB | 100132424 |
| 210003632 | 210009449 | 1.6 | 118.8 | null | null | 2018-10-05 | null | null | null | TCH | 100630244 |
| 210003725 | 210009451 | 1.84 | 69.8 | Palliative (P) | 2017-03-06 | 2017-06-21 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100388097 |
| 210003827 | 210009453 | null | null | null | null | 2019-08-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 100114946 |
| 210003842 | 210009454 | null | 78.3 | Neo-adjuvant (N) | 2020-12-13 | 2020-12-27 | FEC 60 or 75 | null | N | FEC | 101238416 |
| 210003568 | 210009459 | 1.54 | 66.5 | Neo-adjuvant (N) | null | 2019-05-28 | BLEOMYCIN | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100026134 |
| 210003837 | 210009460 | 1.75 | null | null | 2021-04-10 | 2021-05-01 | null | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100005403 |
| 210002579 | 210010095 | null | 78.3 | null | null | 2019-06-07 | Trastuzumab | null | null | TRASTUZUMAB | 101193499 |
| 210002580 | 210010096 | 1.56 | 81.1 | Adjuvant (A) | 2018-08-13 | 2018-11-26 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100860263 |
| 210002581 | 210010097 | 1.66 | 114 | Adjuvant (A) | null | 2019-05-06 | Trastuzumab | null | N | TRASTUZUMAB | 101665933 |
| 210002582 | 210010098 | null | 57 | null | 2021-07-20 | 2021-10-21 | Docetaxel | 02 | null | DOCETAXEL | 100693101 |
| 210002583 | 210010099 | 1.58 | 75.9 | Palliative (P) | 2018-12-17 | 2019-02-04 | Docetaxel | 02 | N | DOCETAXEL | 100273667 |
| 210002584 | 210010100 | 1.58 | 77 | Adjuvant (A) | 2016-06-19 | 2016-08-27 | Docetaxel | 02 | N | DOCETAXEL | 100119633 |
| 210002585 | 210010101 | 1.69 | 68.25 | Adjuvant (A) | 2019-10-16 | 2020-01-16 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100680230 |
| 210002587 | 210010102 | 1.45 | 83 | Adjuvant (A) | 2020-05-20 | 2020-09-10 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100698588 |
| 210002590 | 210010104 | null | 70.7 | null | null | 2021-07-09 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101244281 |
| 210002591 | 210010105 | 1.73 | 72.6 | Adjuvant (A) | 2016-09-22 | 2016-12-24 | Trastuzumab | null | N | TRASTUZUMAB | 100810001 |
| 210002593 | 210010106 | 1.6 | 55.3 | Adjuvant (A) | 2018-05-29 | 2018-06-03 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101281773 |
| 210002596 | 210010108 | 1.78 | 74.9 | Adjuvant (A) | 2018-11-30 | 2020-03-21 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101122396 |
| 210002599 | 210010110 | 1.65 | 58.2 | null | 2016-11-18 | 2018-01-31 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101220811 |
| 210002602 | 210010112 | null | 78 | null | 2019-09-04 | 2020-02-03 | Docetaxel | 02 | null | DOCETAXEL | 101510230 |
| 210002603 | 210010113 | 1.56 | 160 | Adjuvant (A) | null | 2018-10-19 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100301316 |
| 210002605 | 210010114 | 1.76 | 68 | Adjuvant (A) | null | 2022-04-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100062568 |
| 210002608 | 210010116 | 1.67 | 83.5 | Adjuvant (A) | 2019-05-29 | 2019-06-03 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100579976 |
| 210002610 | 210010118 | null | 81 | null | null | 2021-11-08 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101722795 |
| 210002612 | 210010120 | null | 52.9 | Palliative (P) | 2021-12-05 | 2022-01-03 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100437174 |
| 210002614 | 210010122 | 1.75 | 97.7 | Adjuvant (A) | null | 2016-10-25 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101380607 |
| 210002615 | 210010123 | 1.65 | 78.9 | Adjuvant (A) | 2020-04-22 | 2020-04-23 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101606428 |
| 210002616 | 210010124 | null | 90.9 | null | null | 2020-09-23 | Trastuzumab | 02 | null | TRASTUZUMAB | 100330122 |
| 210002618 | 210010125 | null | 71 | Adjuvant (A) | 2016-02-07 | 2016-09-20 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101791657 |
| 210002621 | 210010128 | 1.63 | null | Adjuvant (A) | null | 2020-05-06 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 100980853 |
| 210002623 | 210010130 | 1.66 | 83.9 | Adjuvant (A) | 2017-03-10 | 2017-08-11 | Docetaxel | null | N | DOCETAXEL | 101029144 |
| 210002624 | 210010131 | 1.71 | 85.1 | Neo-adjuvant (N) | 2018-03-02 | 2018-04-13 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100432041 |
| 210002625 | 210010132 | 1.55 | 109 | Adjuvant (A) | null | 2019-07-16 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100085288 |
| 210002628 | 210010133 | 1.64 | 58.1 | Palliative (P) | 2018-07-12 | 2018-07-31 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101416903 |
| 210002632 | 210010135 | 1.73 | 94.7 | Palliative (P) | 2016-10-25 | 2017-01-02 | Trastuzumab | null | N | TRASTUZUMAB | 100208875 |
| 210002633 | 210010136 | 1.75 | 69.7 | Palliative (P) | null | 2018-03-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100957328 |
| 210002634 | 210010137 | 1.67 | 56.9 | Adjuvant (A) | 2021-04-10 | 2021-04-19 | Paclitaxel (2 or 3 weekly) | 02 | N | PACLITAXEL | 100165613 |
| 210002639 | 210010139 | 1.58 | 109 | Adjuvant (A) | null | 2017-04-11 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101227330 |
| 210002644 | 210010141 | null | 77.6 | null | null | 2018-12-12 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101704040 |
| 210002648 | 210010142 | 1.6 | 74.8 | Adjuvant (A) | 2019-01-10 | 2019-01-10 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101843835 |
| 210002650 | 210010143 | 1.7 | 88.8 | Adjuvant (A) | 2016-03-10 | 2017-06-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100570355 |
| 210002651 | 210010144 | 1.8 | 54 | Palliative (P) | 2019-01-19 | 2019-02-03 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100764006 |
| 210002652 | 210010145 | null | 75 | null | 2019-05-06 | 2019-07-23 | Docetaxel | 02 | null | DOCETAXEL | 101398824 |
| 210002653 | 210010146 | 1.62 | 69.3 | Adjuvant (A) | null | 2018-07-04 | Docetaxel | 02 | N | DOCETAXEL | 100093279 |
| 210002657 | 210010148 | null | 68.8 | null | null | 2020-09-29 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101287575 |
| 210002659 | 210010149 | null | 71.9 | Adjuvant (A) | null | 2020-12-23 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100644853 |
| 210002660 | 210010150 | 1.64 | 80.1 | null | null | 2019-02-04 | Docetaxel | 02 | null | DOCETAXEL | 101045872 |